These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 18372318

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Arrhythmias in hemodialysis patients.
    Voroneanu L, Covic A.
    J Nephrol; 2009; 22(6):716-25. PubMed ID: 19967650
    [Abstract] [Full Text] [Related]

  • 3. Sympathetic overactivity and sudden cardiac death among hemodialysis patients with left ventricular hypertrophy.
    Nishimura M, Tokoro T, Nishida M, Hashimoto T, Kobayashi H, Yamazaki S, Imai R, Okino K, Iwamoto N, Takahashi H, Ono T.
    Int J Cardiol; 2010 Jun 25; 142(1):80-6. PubMed ID: 19168236
    [Abstract] [Full Text] [Related]

  • 4. The current status of interventions aiming at reducing sudden cardiac death in dialysis patients.
    de Bie MK, van Dam B, Gaasbeek A, van Buren M, van Erven L, Bax JJ, Schalij MJ, Rabelink TJ, Jukema JW.
    Eur Heart J; 2009 Jul 25; 30(13):1559-64. PubMed ID: 19465437
    [Abstract] [Full Text] [Related]

  • 5. Left-ventricular hypertrophy and coronary artery disease.
    Pierdomenico SD.
    Am J Hypertens; 2007 Oct 25; 20(10):1036-7. PubMed ID: 17903684
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevention of sudden cardiac death in dialysis patients: drugs, defibrillators or what else.
    Passman R.
    Blood Purif; 2013 Oct 25; 35(1-3):49-54. PubMed ID: 23343546
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Late complications of diabetes mellitus: risk factors in patients on sulfonylureas for more than 10 years.
    Hoshi M, Fujita S.
    Jpn J Med; 1991 Oct 25; 30(6):616-7. PubMed ID: 1798228
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical experience with Glurenorm in type 2 diabetics with renal insufficiency].
    Rybka J, Gregorová A, Zmydlená A.
    Vnitr Lek; 1988 Aug 25; 34(8):786-92. PubMed ID: 3176368
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Metformin should not be used by patients with reduced renal function].
    Gudmundsdottir H, Brørs O, Os I.
    Tidsskr Nor Laegeforen; 2008 Apr 17; 128(8):936-7. PubMed ID: 18431417
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Not Available].
    Lüthi L, Kistler A, Nowak A.
    Praxis (Bern 1994); 2017 Apr 17; 106(11):561-570. PubMed ID: 28537111
    [No Abstract] [Full Text] [Related]

  • 20. Cardiac disease in patients with end-stage renal disease.
    Staffeld CG, Pastan SO.
    Cardiol Clin; 1995 May 17; 13(2):209-23. PubMed ID: 7614511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.